Tessa Lai
About Tessa Lai
Tessa Lai is the 临床供应链亚太负责人 at 百时美施贵宝 in Shanghai, with over 15 years of experience in the pharmaceutical industry.
Title
Tessa Lai is the 临床供应链亚太负责人 at 百时美施贵宝, overseeing clinical supply chain operations across the Asia-Pacific region. She is based in 上海 静安区.
Company
Tessa Lai joined Bristol-Myers Squibb in March 2017. The company, also known as 百时美施贵宝, is where she currently serves as the head of the clinical supply chain for the Asia-Pacific region. She has successfully managed numerous significant clinical supply chain projects contributing to the delivery of clinical trials.
Education and Expertise
Tessa Lai holds a Master's degree in IMBA from The University of Hong Kong, completed in 2021. She also earned a Master's degree in 药剂学 from 四川大学华西药学院, obtained in 2010. Her academic journey began with a Bachelor's degree in 制药工程 from 西南交通大学, completed in 2007. This extensive educational background underpins her expertise in pharmaceutical sciences and supply chain logistics.
Professional Background
Tessa Lai's professional career spans over 15 years in the pharmaceutical industry. She began as a PDS scientist at 药明康德 from 2010 to 2012. She then moved to Eli Lilly and Company, where she served as a Project Manager from 2012 to 2017 in Shanghai. Her experience in managing complex supply chain operations in multinational pharmaceutical companies is extensive.
Achievements
Throughout her career, Tessa Lai has worked on significant clinical supply chain projects that have successfully contributed to the delivery of clinical trials across the Asia-Pacific region. Her proven track record includes managing complex supply chain operations, demonstrating her extensive expertise and ability to handle intricate logistics in the pharmaceutical industry.